Patents Represented by Attorney Theodore R. Furman
  • Patent number: 6668416
    Abstract: A toothbrush having a resiliently flexible composite region between its head and handle which comprises one or members of generally triangular shape in section either made of a resilient elastomeric material different to the hard plastic material of the toothbrush head and handle, or made of a hard plastic material.
    Type: Grant
    Filed: February 27, 2002
    Date of Patent: December 30, 2003
    Assignee: GlaxoSmithKline Consumer Healthcare GmbH & Co. KG
    Inventors: Matthias Georgi, Hans Krämer
  • Patent number: 6660299
    Abstract: Bacterial infections may be treated using a high dosage regimen of amoxycillin. Preferably, the dosage is provided by a bilayer tablet.
    Type: Grant
    Filed: July 24, 2001
    Date of Patent: December 9, 2003
    Assignee: Beecham Pharmaceuticals Limited
    Inventors: Creighton P. Conley, John A. Roush, Kevin H. Storm
  • Patent number: 6660754
    Abstract: This invention is an improved method for reducing or eliminating tobacco usage and the nicotine dependency associated with tobacco usage by gradually decreasing an individual's tobacco consumption over a time period while replacing nicotine from tobacco with an alternative nicotine source.
    Type: Grant
    Filed: February 15, 2000
    Date of Patent: December 9, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: Theodore K. Kyle, Saul Shiffman
  • Patent number: 6649617
    Abstract: A method of treating a CNS injury to the brain, in a mammal in need of treatment, which comprises administering to said mammal an effective amount of a cytokine suppressive binding protein compound of formula I wherein the radicals are defined herein.
    Type: Grant
    Filed: March 27, 2001
    Date of Patent: November 18, 2003
    Assignee: SmithKline Beecham Corporation
    Inventor: Jerry Leroy Adams
  • Patent number: 6645989
    Abstract: Novel 2,4,5-triaryl imidazole compounds and compositions for use in therapy.
    Type: Grant
    Filed: March 27, 2001
    Date of Patent: November 11, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: Jerry Leroy Adams, Timothy Francis Gallagher, John C. Lee, John Richard White
  • Patent number: 6610695
    Abstract: Novel 2,4,5-triaryl substituted imidazole compounds and compositions for use in therapy of CSBP/RK/p38 mediated diseases.
    Type: Grant
    Filed: March 22, 2000
    Date of Patent: August 26, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: Jerry L. Adams, Dennis Lee, Scott A. Long
  • Patent number: 6607749
    Abstract: The present invention relates to a novel pharmaceutical composition and process for preparing swallowable rapidly disintegrating methylcellulose and lipstatin derivatives together in combination with a suitable diluent and excipients.
    Type: Grant
    Filed: March 6, 2001
    Date of Patent: August 19, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: Bruce P. Daggy, Kenneth G. Mandel
  • Patent number: 6583283
    Abstract: This invention relates to novel crystalline polymorphic forms, Form I, II and IV of Cipamfylline, methods of preparation, and use thereof in the treatment of PDE4 and TNF mediated diseases.
    Type: Grant
    Filed: August 15, 2000
    Date of Patent: June 24, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: Drake S Eggleston, Ian Robert Lynch
  • Patent number: 6509044
    Abstract: A process for preparing an aqueous composition for the preparation of optically clear products, especially beverages, having enhanced stability in syrup and bioavailability for human or animal healthcare. The compositions include an oil soluble ingredient and a primary and a secondary surfactant which match the fatty acid profile of the oil soluble ingredient and follow specific ratios of oil soluble ingredient to emulsifier and specific ratios of primary to cosurfactant.
    Type: Grant
    Filed: April 2, 2001
    Date of Patent: January 21, 2003
    Assignee: SmithKline Beecham p.l.c.
    Inventors: Maarten Van Den Braak, Andrew Symonds, Michael Anthony Ford
  • Patent number: 6495051
    Abstract: A method for separating a blood component, e.g., fibrin monomer, from blood or plasma. The method utilizes a container with a reaction chamber for receiving the plasma. The reaction chamber is defined by a wall and an agent is supplied to the reaction chamber for converting the fibrinogen content of the plasma into a non-cross-linked fibrin polymer. The method also utilizes a device for centrifuging the reaction chamber with the plasma and the agent to a degree sufficient for separating the non-cross-linked fibrin polymer from the plasma, for depositing the polymer on the outer wall of the reaction chamber, and for expelling the remaining plasma from the reaction chamber. A solvent is supplied to the reaction chamber for dissolving the non-cross-linked fibrin polymer. The solvent is supplied to the reaction chamber in a first amount for dissolving the non-cross-linked fibrin polymer which is less than the total amount of solvent for dissolving the polymer.
    Type: Grant
    Filed: September 29, 2000
    Date of Patent: December 17, 2002
    Assignee: Bristol-Myers Squibb Company
    Inventors: Gautom Bhaskar, Glenn Jorgensen
  • Patent number: 6492494
    Abstract: The invention provides a kit for preparing a fibrin sealant either (A) comprising: (a) a fibrin monomer preparation; (b) a stabilizing preparation containing a clot-preserving effective amount of a fibrinolysis-inhibiting protein; and (c) a non-enzymatic polymerizing agent preparation effective to convert the fibrin monomer preparation into a fibrin clot; or (B) comprising: (a′) a fibrin monomer preparation comprising a fibrin monomer and a clot-preserving effective amount of a of a fibrinolysis-inhibiting protein; and (c′) a polymerizing agent preparation effective to convert the fibrin monomer preparation into a fibrin clot.
    Type: Grant
    Filed: December 9, 1998
    Date of Patent: December 10, 2002
    Assignee: Bristol-Myers Squibb Company
    Inventor: Stewart A. Cederholm-Williams
  • Patent number: 6393369
    Abstract: A blood processor is provided with a computer and memory, and external to the blood processor there is provided a general purpose computer system programmed with a convenient interface for creating scripts; the general purpose computer system translates the scripts into custom interpretive code adapted for processing by the computer in the blood processor, and the code is written into the memory of the blood processor via the computer in the blood processor.
    Type: Grant
    Filed: April 30, 1999
    Date of Patent: May 21, 2002
    Assignee: Bristol-Myers Squibb Company
    Inventor: Raymond A. Carr
  • Patent number: 6387263
    Abstract: An improved plasma separation device and method involve the use of a retaining means with a centrifugal plasma separation device for retaining unwanted blood components, e.g., lipids or lipoproteins, from passing from a separation chamber in the device to a collection chamber in the device along with the separated plasma.
    Type: Grant
    Filed: August 28, 2000
    Date of Patent: May 14, 2002
    Assignee: Bristol-Myers Squibb Company
    Inventors: Gautam Bhaskar, Glenn A. Joergensen
  • Patent number: 6359100
    Abstract: A polyurethane adhesive composition preferably having pressure sensitive characteristics that is non-cytotoxic and methods of making the same which is especially useful for medical applications such as ostomy and wound care.
    Type: Grant
    Filed: January 25, 1999
    Date of Patent: March 19, 2002
    Assignee: Bristol-Myers Squibb Company
    Inventors: Fritz Hostettler, Peter Wachtel
  • Cap
    Patent number: D476568
    Type: Grant
    Filed: July 23, 2002
    Date of Patent: July 1, 2003
    Assignee: GlaxoSmithKline Consumer Healthcare
    Inventors: Hartmut Mechtold, Ralf Welter
  • Patent number: D477222
    Type: Grant
    Filed: August 30, 2002
    Date of Patent: July 15, 2003
    Assignee: SmithKline Beecham Corporation
    Inventor: James L. Pitassi
  • Patent number: D481456
    Type: Grant
    Filed: July 29, 2002
    Date of Patent: October 28, 2003
    Assignee: SmithKline Beecham p.l.c.
    Inventors: Stephen Mark McAllister, Brian Hewitt
  • Patent number: D483184
    Type: Grant
    Filed: November 21, 2002
    Date of Patent: December 9, 2003
    Assignee: GlaxoSmithKline Consumer Healthcare GmbH & Co. KG
    Inventors: Christoph Geiberger, Wolf-Dieter Müller
  • Patent number: D485073
    Type: Grant
    Filed: January 31, 2003
    Date of Patent: January 13, 2004
    Assignee: GlaxoSmithKline Consumer Healthcare GmbH & Co. KG
    Inventor: Tamas Berde
  • Patent number: D485074
    Type: Grant
    Filed: January 31, 2003
    Date of Patent: January 13, 2004
    Assignee: GlaxoSmithKline Consumer Healthcare GmbH & Co. KG
    Inventor: Tamas Berde